Peter Mutzenbecher

Working with selected biotech, specialty pharma, animal health companies and start-ups, focus on Leadership, Commercialization, Scale Up / Transformation, e.g.: • Strategic support to the CEO of global start up Animal Health (commercial excellence, leadership advise) • Leadership coaching, sparring and mentoring of C-level executives and founding teams at WERK1 Munich (a leading deep-tech / health-tech start-up hub in Bavaria) In parallel seeking my next full-time operational role. Immediately available.

• Building the organization from 1 product to 4 products, 2 BUs and close to 100 FTE, resulting in a more than 10fold increase in sales • Leading Onco-Haematology team through AMNOG and towards successful launches of 2 new products (EU Awards for best performance) • Building the Inflammation and Auto-Immunity (IAI) team from zero to launch first ever approved treatment for Vitiligo in 23 • Developing high-performing leadership team, incl talent development into German Leadership role and into EU roles

- Responsible for business in Immuno-Oncology, Hematology, Rheumatology, Cardiology, HIV and HepC; overall sales >$100M - Leading organization of 70 employees to accelerated growth of key brands, while improving profitability - Managed team to successful expansion of Immuno-Oncology portfolio with 8 launches in last 2 years - Member of the US Leadership Team

- Led team of 40 employees to accelerated sales growth of +250% - Led team to successful launch of new MOA (Immuno-Oncology) in Metastatic Melanoma (President´s Award for Access) and a successful line extension of CML drug into 1st L, applying innovative formulary access strategy - Redesigned structure with focus on superior customer experience with focus on innovative value added projects - Member of Spanish Management Team and of European Disease Area Committee

- Led BMS Diabetes alliance with AstraZeneca, acting as Launch Lead for Diabetes drug Onglyza (at launch with total of >300 Reps) and responsible for preparation of franchise expansion in close cooperation with EU Matrix Teams - Led BMS CV alliance with Pfizer, responsible for pre-launch preparation for Eliquis - Member of the BMS/AstraZeneca Alliance Operating Committee, BMS/Pfizer Alliance Operating Committee, EU Matrix Teams for Diabetes and Cardiovascular

- Led a team of up to 105 employees (FLM, SF retail and hospital) to N1 position at BMS in Germany, with sales above 70MEuro - Took over additional responsibility for European pilot of Diabetes Alliance with AZ (President’s award for leadership)

- Managed a team of 12 reps with responsibility in CV & Metabolics, Urology and Antibiotics, leading the region from 15th to 3rd in Germany within 2 years

- Co-led launch preparation of Kinzal (Telmisartan) and roll out of brand plan

- Management function at global headquarter - Managed the Nordic P&L in close cooperation with local GM, coordinating all region related strategies and actions - Member of EU Markets Team

Area of responsibilty: Antidepressant, CV & Metabolics, Antibiotics - Including 5 months at Bayer HQ Latin America, Bayer AG, Leverkusen, Germany - Sales Rep + Assistant to national Sales Manager (13 months) - JPM Launch of Seropram (Citalopram, antidepressant) (12 months) - Assistant to local BUH, projects in controlling, logistics and budgeting (5 months)

- Marketing and Sales projects for the division of crop protection - Development of regional concepts in cooperation with local sales managers

Marketing, Industriebetriebslehre, Internationales Management